Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
Submitted by
admin
on December 7, 2009 - 12:48pm
Source:
BNET Pharma
News Tags:
AstraZeneca
antidepressants
Seroquel
Targacept
Headline:
Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
Do Not Allow Advertisers to Use My Personal information
